Back to article: Inhibitory DAMPs in immunogenic cell death and its clinical implications

FIGURE 1: Blockade of inhibitory DAMP convert gemcitabine into an ICD-inducer that primes a durable CD8+ T cell response. (a) Gemcitabine as a single chemotherapy induces tolerogenicity. (b) When gemcitabine is complemented with iDAMP blockade, an antitumoral immune response is elicited. (c) iDAMP blockade is expected to augment chemotherapy and immune checkpoint blockade therapies.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.